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Abstract
Background
Erythema nodosum leprosum (ENL) is a common immune-mediated complication of lepro-
matous (LL) and borderline lepromatous (BL) leprosy. Most patients experience chronic or
multiple acute ENL over many years during an economically active period of their lives. Un-
derstanding the economic burden of ENL is essential to provide effective patient support,
yet this area has not been investigated.
Methods
Ninety-one patients with LL or BL leprosy attending a leprosy hospital in Purulia district of
West Bengal, India, were interviewed using a structured questionnaire. Cases (n = 53) were
identified as those who had one or more episodes of ENL within the last 3 years. Controls
(n = 38) had LL or BL leprosy but no history of ENL. Data were collected on household in-
come, direct and indirect costs, and coping strategies.
Findings
The total household cost was Rs 1543 per month or 27.9% (IQR 13.2-52.6) of monthly
household income for cases, and Rs 237 per month or 4.9% (IQR 1.7-13.4) of monthly
household income for controls. Indirect costs accounted for 65% of total household costs
for cases. Direct costs accounted for the remaining 35% of household costs, and resulted
almost entirely from treatment-seeking in the private sector. Total household costs ex-
ceeded 40% of household income for 37.7% of cases (n = 20) and 2.6% of controls (n = 1)
[1 USD = 59 INR].
Interpretation
Households affected by ENL face significant economic burden and are at risk of being
pushed further into poverty. Health policy should acknowledge the importance of private
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sector provision and the significant contribution to total household costs of lost productivity
(indirect cost). Further work is needed to explore this area and identify solutions.
Author Summary
Erythema nodosum leprosum (ENL) is a common complication of leprosy and an impor-
tant cause of nerve damage and disability. In most cases, ENL causes chronic or recurrent
episodes of ill-health over many years. In this study, we show that having a family member
affected by ENL places considerable financial burden on households in rural India. House-
hold costs resulted predominantly from the impact of ENL on the productivity (ability to
earn money) of household members. Out of pocket expenditure on treatment-seeking in
the private sector accounted for the remaining costs. Leprosy affects poor and margina-
lised communities in low- and middle-income countries across the world; households
affected by ENL are at risk of being pushed further into poverty. The findings of this study
support the need to better understand ENL and develop improved strategies for the pre-
vention and management of ENL.
Introduction
Leprosy is a disease of poverty, affecting poor and marginalised communities in tropical coun-
tries throughout the world.[1] More than 200,000 new cases of leprosy are registered world-
wide annually, with 60% in India. Leprosy reactions occur in up to 50% of patients with
multibacillary leprosy and cause nerve damage and disability.[2,3] Two types of reaction can
occur: type 1 reaction (T1R) and type 2 reaction (T2R) or erythema nodosum leprosum (ENL).
At the end of the first quarter of 2014 there were 180,618 leprosy patients on record for treat-
ment globally (estimated prevalence rate 0.32 per 10,000 population)[4] however this does not
include those patients who have completed treatment and are at risk of developing reactions.
The lepromatous (LL) and borderline lepromatous (BL) forms of leprosy are characterised
by low cell-mediated immunity to the causative organismMycobacterium leprae. There is
uncontrolled proliferation and dissemination of leprosy bacilli resulting in extensive infiltra-
tion of the skin and other organs. Erythema nodosum leprosum (ENL) is an immune-mediated
complication affecting patients with LL and BL leprosy. Patients with ENL have widespread
crops of tender, erythematous swellings in the skin, and other organs are often inflamed. The
physical impact of ENL is significant—patients suffer repeated episodes of ill health over many
years and many develop impaired organ function, deformity and disability.[5] Patients need
prolonged courses of high-dose steroids or thalidomide to control inflammation, and this can
cause adverse effects including steroid dependency.[6]
Families with ENL are affected by out of pocket expenditure for treatment-seeking (direct
cost) and loss of income resulting from reduced productivity (earning potential) of household
members (indirect cost). There are some data on the economic burden of malaria and visceral
leishmaniasis on households in low-income countries,[7–11] however none for leprosy.
Understanding the economic burden of ENL is essential to provide effective patient support
and to inform researchers, healthcare professionals, health policy makers and managers of
control programmes.
Qualitative research has provided some insight into the social and economic consequences
of leprosy; however quantitative data on the economic impact of leprosy and ENL do not exist.
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The Social Welfare Department of the Government of Delhi, India, operate financial assistance
schemes for the families of patients affected by leprosy. This financial support is helpful for
eligible families, however the schemes are based on a limited understanding of the costs affect-
ing households, have no impact on preventing or reducing these costs, are neither suitable nor
efficient long-term solutions, and may not necessarily be available to the families who are most
in need of support (many do not have bank accounts). Socio-economic rehabilitation (SER)
and microfinance programs can provide much needed financial support for leprosy patients
and their families.[12,13] The International Federation of Anti-Leprosy Associations (ILEP)
has produced guidelines which identify the broad principles of effective SER programmes,
however the design of such programmes would greatly benefit from detailed quantitative data
on household costs. Understanding the specific problems faced by families affected by ENL
and how costs arise will allow the development of solutions that are appropriate to the needs of
the target population. Understanding the magnitude of economic burden on households will
predict the degree of financial support required by families and ensure that interventions for
ENL are socially viable (any costs to the patient are financially acceptable).
In this study we determined the economic impact of having a family member with erythema
nodosum leprosum (ENL) on households in rural India. We estimated direct and indirect costs
associated with ENL and expressed these in relation to household income, and investigated the
coping strategies used by households. We hypothesised that patients with lepromatous (LL)
and borderline lepromatous (BL) leprosy complicated by ENL would incur greater household
costs than those without ENL.
Methods
Ethical considerations
Ethics approval was obtained from the London School of Hygiene and Tropical Medicine
(LSHTM) MSc Research Ethics Committee (ref 012–275) and from the ethics committee of
The Leprosy Mission (TLM) Trust India, for this study to be carried out in TLM hospital Puru-
lia, West Bengal, India. Informed written consent was provided by all adult patients or the par-
ent or guardian if the patient was a child.
Study design
The perspective of this study was microeconomic (households). We aimed to determine the
economic impact of ENL on families. We assessed losses associated with the market economy
only, providing estimates of direct costs and indirect costs (lost market production). These
costs were combined to provide an estimate of the net impact of ENL on households’ opportu-
nities to consume non-health goods and services (the primary outcome of interest). An appro-
priate counterfactual (control patients with LL/BL leprosy but no history of ENL) was used for
comparison of cost data. The broader effects of ill-health on economic welfare, including
reductions in health status and leisure time, were not considered in this analysis. The cost to
the rest of the society of ENL was not explored.
Patient selection
All patients with a diagnosis of lepromatous (LL) or borderline lepromatous (BL) leprosy were
eligible for inclusion in the study. Cases had LL or BL leprosy and one or more episodes of
ENL within the last 3 years. Controls had LL or BL leprosy but no history of ENL. Consecutive
patients attending the hospital outpatient department and those admitted to the hospital dur-
ing the study period (19th June—27th July 2013) were recruited. Published case definitions for
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ENL were used.[5] Erythema nodosum leprosum (ENL) was defined as an eruption of tender
erythematous skin nodules; fever and evidence of other organ inflammation may be present.
Single acute ENL was one episode lasting less than six months with no recurrence of ENL while
receiving prednisolone, no increase in severity requiring an increased steroid dose and no
recurrence after the prednisolone has stopped. Multiple acute ENL was more than one episode
with the same characteristics as acute single ENL. Chronic ENL was an episode lasting more
than six months and could include single and multiple episodes.
Data collection
Data were obtained using a structured questionnaire, administered to the patient or to the
parent or guardian if the patient was a child. All interviews were conducted in a private and in-
formal setting in the hospital outpatient department, by the first author (DC). Translation ser-
vices were provided by an existing member of staff at TLM Purulia (BM). Patients were
approached in the hospital waiting room, in between appointments with different members of
hospital staff, and were recruited and interviewed with minimal delay. The objectives of the
study were outlined to patients before starting the questionnaire, and it was explained that
there would be no financial reward or adjustment to treatment costs based on the responses
provided during the interview. Patients were generally enthusiastic to participate and help with
the study. The questionnaire was piloted on 8 eligible patients (5 cases, 3 controls) allowing im-
provements to be made to questionnaire content. The results from the pilot interviews were
not included in the analysis. Patients were interviewed once only. The questionnaire collected
data on clinical history, household income and socioeconomic status, treatment-seeking
behaviour, direct and indirect costs, and coping strategies. Direct and indirect costs were spe-
cific to leprosy; the presence of other comorbidities and their associated costs was not ascer-
tained. Data were gathered on the number of episodes and type (chronicity) of ENL.[5] The
clinical history provided the duration of ill-health (time since diagnosis of leprosy for controls,
time since first episode of ENL for cases) and in doing so defined the time dimension or recall
window for which cost and income data were captured. These data were collected retrospec-
tively for the full duration of ill-health, up to a maximum of 3 years. Total costs for the whole
recall window were converted to an average cost per month and presented as a proportion of
monthly household income. This allowed costs to be compared between patients with varying
duration of ill-health.
The occupations of all economically active household members and their daily cash earn-
ings were reported by the patient, including regular cash income from family members not liv-
ing at home. We defined the household as all persons living in the housing unit and those
persons not living at home but who contribute to the generation and/or consumption of house-
hold wealth. All agricultural output was considered to contribute to income regardless of
whether the products were sold or consumed within the household. All government income
support (pension and disability allowance) was included in estimates. Socioeconomic status
was assessed using place of residence (urban or rural) and household asset data. The household
assets were the same as those recorded in the National Family Health Survey (NFHS-3) India,
2005–2006.[14]
Direct costs
Data were gathered on treatment-seeking behaviour during the period of ill-health. Medical
and non-medical costs were recorded per visit, for all healthcare providers visited. Medical di-
rect costs included provider fees (for consultations and hospital admissions) and payment for
investigations, medicines and other treatments. Multidrug therapy (MDT) was available to
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patients free of charge from all health providers, however not all providers received a free
supply of MDT. The cost to these providers of procuring MDT was not determined. Non-
medical direct costs included transport costs to and from the health facilities and any addition-
al expenditure on food and other non-medical goods or services. Invoices were available
electronically for all inpatient and outpatient episodes at TLM Purulia, and provided an exact
breakdown of the medical costs (as listed above) for each episode. Invoices also included the
total medical cost per episode (unadjusted cost) and the amount the patient could afford to pay
(adjusted cost). The difference between these two values was the subsidy provided (cost
incurred) by the hospital for that episode. Cost data presented in this paper are adjusted unless
otherwise specified, as these represent the actual costs incurred by the family (the outcome of
interest). Unadjusted costs are included for completeness and these represent the amount the
family should have paid if they were able to (without subsidised treatment costs at TLM Puru-
lia). We defined catastrophic health expenditure as adjusted direct costs in excess of 40% of
total household income.
Indirect cost
Indirect costs refer to the reduction in household productivity resulting from the interruption
of normal or preferred activities of household members. We used an output-based approach to
value the time diverted as a result of ill-health in all persons contributing to the economic pro-
ductivity or wealth of the household. For those with formally-paid wages, the indirect cost was
the daily earnings multiplied by the number of days lost. The contribution of individual house-
hold members to agricultural output was not determined. Study participants were asked to re-
port the overall loss of income from agriculture during the period of ill-health. When provided
with information on the reduction in agricultural output local market prices were used to de-
termine the monetary value. The market values reported by patients were remarkably consis-
tent. The use of an output-based approach was appropriate in this setting, allowing us to
account for the significant fluctuations in work intensity that occurred during the year and the
coping strategies used to minimise productivity losses, for example recruitment of additional
labour to minimise farming losses. The cost of hiring external labour was valued using average
local wage rates for males and females. Coping strategies used to generate money, for example
selling assets or taking a loan, were identified but considered separately and not factored into
cost data. Time diverted by those engaged in unpaid production (children, the elderly, jobsee-
kers and women engaged in domestic work) was considered valueless for the purpose of this
analysis and excluded from estimates of indirect costs.
Statistical methods
Data were analysed using Minitab 17. Household income and cost data are reported using me-
dians and interquartile ranges. The Mann-Whitney (Wilcoxon ranksum) test was used to com-
pare differences in costs between cases and controls. 1 USD = 59 INR; Bloomberg 19 June 2013.
Results
Clinical details
Ninety-one patients (53 cases and 38 controls) were identified and all agreed to be interviewed
for the study. There were no drop outs at any stage. All patients had lepromatous (n = 53) or
borderline lepromatous (n = 38) leprosy. Clinical details are shown in table 1.
The median time since the first episode of ENL in cases was 24 months (IQR 14–36).
Seventy-seven percent of cases (n = 41) had chronic ENL and 23% (n = 12) experienced
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multiple acute episodes. Cases had 2 hospital admissions (IQR 1–3) each lasting an average 35
days (IQR 14–130) whilst controls had 1 admission (IQR 1–1).
Household income and socioeconomic status
Monthly household income was Rs 6000 (IQR 3600–8100) and 6000 (IQR 3895–8370) for cases
and controls respectively. Household size ranged from 2 to 18 persons (median 5 persons,
IQR 4–7) and was similar for cases and controls. Daily manual labour was the major source of in-
come and generated a median Rs 5100 (IQR 3525–7925) per month. Small-scale agriculture was
a source of income in 37 households, generating a median Rs 750 (IQR 540–1600) per month.
Three households received a regular cash income from a family member not living at home, and
three received government support (disability allowance or pension). Most patients (92%) lived
in a small village. There was no correlation between household assets and household income.
Treatment-seeking and direct costs
The total direct cost per month (adjusted) was Rs 465 (IQR 217–738) for cases and Rs 175
(IQR 92–386) for controls, or 7.5% and 3.7% of monthly household income for cases and con-
trols respectively. The monthly total direct cost, as a percentage of household income, was
3.2% higher in cases than controls (Mann-Whitney test; 95% CI 1.2–5.8, W = 2814.5,
p = 0.0025). The proportion of households facing catastrophic health expenditure was 11%
(n = 6) for cases and 0% (n = 0) for controls. The unadjusted direct cost was Rs 587 (IQR
235–1651) for cases and Rs 204 (IQR 104–248) for controls, or 10.1% and 3.7% of monthly
household income for cases and controls respectively. TLM Purulia incurred an average cost
per patient of Rs 5026 (IQR 180–27079) for cases (n = 31) and Rs 200 (IQR 45–965) for con-
trols (n = 17) by providing subsidised service to patients (see Fig. 1). This illustrates the extent
to which families were unable to cope with the increased treatment costs associated with ENL.
Treatment-seeking in the private sector caused 96% and 99% of total direct costs for cases
and controls respectively.
Table 1. Patient characteristics and clinical details.
Cases (n = 53) Controls (n = 38)
Patient characteristics
Age (years) 28 (23–39) 32 (21–40)
Gender (%)
Male 43 (81) 32 (84)
Female 10 (19) 6 (16)
Clinical details
Leprosy classiﬁcation (%)
LL (lepromatous) 35 (66) 18 (47)
BL (borderline lepromatous) 18 (34) 20 (53)
Time since diagnosis of leprosy (months) 26 (17–42) 17 (7–34)
MDT treatment duration (months) 20 (13–24) 16 (4–24)
Prevalence of leprosy reactions (%)
Type 2 reaction (ENL) 53 (100) 0 (0)
Type 1 reaction 4 (8) 4 (11)
Neuritis 11 (21) 16 (42)
Data are n (%) or median (IQR).
doi:10.1371/journal.pntd.0003431.t001
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Outpatient services at private health providers other than TLM Purulia were sought by 64%
of cases (n = 34) and 47% of controls (n = 18). Traditional healers were consulted by 43% of
cases (n = 23) and 29% of controls (n = 11). The median distance from household to traditional
healer was 10km (IQR 2–30), compared with 45km (IQR 25–78) for all other private health
providers at which outpatient services were consumed. In 41% of patients visiting a traditional
healer (n = 14) transport was by foot or bicycle.
Medical and non-medical costs for inpatient and outpatient episodes at TLM Purulia are
shown below in table 2. Invoices containing these data were not available for episodes with
other healthcare providers.
Indirect costs
The market economy losses resulting from reduced household productivity due to ENL were
significant. The median reduction in monthly household income was Rs 969 (IQR 227–1873)
in cases and Rs 60 (IQR 9–186) in controls, or 18.2% (IQR 5.3–33.7) and 1.4% (IQR 0.1–2.6) of
monthly household income in cases and controls respectively. On average the reduction in
monthly household income was greater in cases than controls by 13.3% (Mann-Whitney test;
95% CI 6.0–21.7, W = 3175, p<0.0001).
The causes of reduced household productivity included physical illness (unwell at home),
hospital admission and attendance at outpatient appointments. Physical illness resulted in a
loss of productivity in 94% of cases (n = 50) and accounted for a median 55% (IQR 27–80) of
Figure 1. Total direct cost as a fraction of household income (per month) in cases and controls.Whiskers contain 100% of the data, not including
extreme values (those data observations which lie more than 1.5*IQR lower than the first quartile or 1.5*IQR higher than the third quartile). The reference
line at cost/income = 0.4 indicates the threshold for catastrophic health expenditure.
doi:10.1371/journal.pntd.0003431.g001
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the total indirect cost incurred by these households. Hospital admission and attendance at
outpatient appointments caused 33% (IQR 12–51) and 15% (IQR 5–60) of total indirect costs
respectively. Seventy-six percent of cases (n = 38) received informal care from an average of 1.2
household members. The time diverted by providing care for cases caused a median loss of in-
come of Rs 725 (IQR 233–1500) per household over the duration of ill-health. These data show
that ENL affects the productivity of patients and other household members and has a signifi-
cant impact on household earning potential.
Total household costs
Having a family member with ENL impacted on household consumption opportunities. The
total household cost per month was Rs 1543 (IQR 681–3175) for cases and Rs 237 (IQR
124–656) for controls, or 27.9% (IQR 13.2–52.6) of monthly household income for cases and
Table 2. Total medical and non-medical costs (per patient) for inpatient and outpatient care at TLM Purulia.
Cases Controls
Median IQR Mean sd Median IQR Mean sd
Distance from home (km) 60 (40–90) 71 (9) 40 (26–49) 42 (5)
Inpatient care n = 48 (91%) n = 20 (53%)
Number of episodes 2 (1–3) 2.4 (1.8) 1 (1–1) 1.1 (0.1)
Medical costs
Medicines 297 (164–11542) 5501 (8806) 162 (92–176) 192 (203)
Other treatment 0 (0–250) 151 (265) 0 (0–250) 106 (168)
Investigations 200 (0–3585) 1555 (2170) 0 (0–0) 21 (48)
Admission fees 3363 (1100–16809) 9483 (12075) 1290 (915–1804) 1414 (526)
Total medical 3712 (1703–31373) 16690 (22558) 1525 (1125–2186) 1734 (679)
Total medical (adjusted) 2851 (1153–7147) 6131 (8650) 1413 (993–1585) 1398 (626)
Non-medical costs
Transport 240 (161–480) 385 (449) 100 (45–140) 111 (94)
Other 0 (0–0) 6 (43) 0 (0–0) 0 (0)
Total non-medical 260 (161–480) 499 (863) 100 (45–140) 111 (94)
Total direct cost 4382 (1916–31743) 17081 (22738) 1734 (1348–2299) 1885 (683)
Total direct cost (adjusted) 3158 (1580–7837) 6523 (8760) 1462 (1091–1885) 1550 (581)
Outpatient care n = 53 (100%) n = 38 (100%)
Number of episodes 15 (6–22) 15.7 (10.7) 10 (4–13) 9.7 (7.6)
Medical costs
Medicines 663 (295–1386) 839 (679) 139 (49–396) 273 (343)
Other treatment 0 (0–0) 40 (120) 0 (0–0) 50 (128)
Investigations 390 (240–485) 377 (185) 185 (130–270) 235 (206)
Consultation fees 180 (90–230) 200 (159) 90 (60–150) 128 (132)
Total medical 1210 (620–1916) 1454 (981) 493 (276–750) 687 (598)
Total medical (adjusted) 1210 (620–1916) 1397 (924) 493 (276–750) 658 (559)
Non-medical costs
Transport 1850 (720–3225) 2485 (2653) 780 (323–1625) 1064 (918)
Other 0 (0–0) 142 (1030) 0 (0–0) 0 (0)
Total non-medical 1850 (720–3330) 2627 (2879) 780 (323–1625) 1064 (918)
Total direct cost 3002 (1404–5690) 4081 (3578) 1302 (650–2554) 1751 (1406)
Total direct cost (adjusted) 3002 (1404–5592) 4024 (3557) 1302 (650–2406) 1723 (1383)
doi:10.1371/journal.pntd.0003431.t002
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4.9% (IQR 1.7–13.4) for controls. On average the total household cost per month, as a percent-
age of household income, was 20.8% higher in cases compared with controls (Mann-Whitney
test; 95% CI 12.6–29.4, W = 3143, p<0.0001). Fig. 2 displays the total household cost for cases
and controls.
The proportion of households with total household costs in excess of 40% monthly house-
hold income was 37.7% (n = 20) for cases and 2.6% (n = 1) for controls. Two cases incurred
total household costs per month in excess of household income (cost/income>1).
Total household costs consisted of 65% indirect costs and 35% direct costs in cases com-
pared with 21% indirect costs and 69% direct costs in controls (see table 3).
Coping strategies
All patients used cash savings on one or more occasions to pay for treatment. Other coping
strategies included selling assets, borrowing money and being gifted money; these were used in
69.8% of cases (n = 37) and 55.3% of controls (n = 21).
Selling assets to generate cash was a strategy used by 32% of cases (n = 17) and 16% of con-
trols (n = 6). Cases sold assets to a median value of Rs 6000 (IQR 2850–17000) compared with
Rs 1850 (IQR 825–3125) for controls. Forty-two percent of cases (n = 22) took a loan of medi-
an value Rs 5000 (IQR 2000–10250) and incurred costs (interest on the loan) ranging from Rs
0 to 11700. Thirty-two percent of controls (n = 12) took a loan of median value Rs 1000 (IQR
850–4250) and incurred costs ranging from Rs 0 to 18000.
Figure 2. Total household cost as a fraction of household income (per month) in cases and controls. The proportion of households with total costs in
excess of 40%monthly household income was 37.7% (n = 20) for cases and 2.6% (n = 1) for controls. Two households (cases) incurred total costs per month
in excess of household income (cost/income>1).
doi:10.1371/journal.pntd.0003431.g002
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Discussion
This is the first study to assess the economic consequences of leprosy at the household level.
We show that having a family member with ENL places considerable financial strain on
households in rural India. The impact of ENL on households was predominantly through indirect
costs, which accounted for 65% of total household costs. By comparison, indirect costs accounted
for only 21% of total household costs for controls. This finding highlights the extent to which
ENL disrupts the normal functioning and productivity of households, and is consistent with the
findings of economic evaluations for other diseases including malaria (indirect costs accounted
for 72–94% of total household costs)[8–10] and visceral leishmaniasis (53% of total costs).[11]
Direct costs resulted almost entirely from treatment-seeking in the private sector. Cases in-
curred greater direct costs, predominantly due to the increased number and duration of hospital
admissions required for treatment of ENL. Most cases were unable to pay in full for the services
consumed at TLM Purulia which placed the hospital under considerable financial strain.
Continued presentation to specialist (private sector) service providers following integration
of leprosy services has been observed in other countries including Nepal and SriLanka.[15,16]
This study did not explore the reasons affecting choice of healthcare provider, however access
is likely to be an important factor. Traditional healers were consulted by cases and controls
more than any other healthcare provider (not including TLM Purulia) and were the closest to
the household.
Limitations
Capturing an appropriate time dimension for the illness was difficult. Our aim was to assess
the economic impact of ENL, as a cause of chronic ill-health, on households over many years.
We used 3 years as the maximum time dimension for which cost data were collected, acknowl-
edging the risk of recall bias. The accuracy of estimates was aided by the availability of detailed
clinical information and cost data from the hospital records at TLM Purulia.
TLM Purulia is a specialist service provider, therefore referral bias may have produced an
atypical study population. The high prevalence of ENL overall (58%) and particularly among
Table 3. Summary of household costs for cases and controls.
Cases Controls
Median (IQR) Mean (sd) Median (IQR) Mean (sd)
Direct cost
Inpatient care n = 49 (92%) n = 20 (53%)
Total inpatient cost 347 (115–1178) 713 (814) 218 (91–650) 409 (456)
Outpatient care n = 53 (100%) n = 38 (100%)
Total outpatient cost 217 (129–351) 334 (364) 108 (60–313) 277 (436)
Total direct cost 587 (235–1651) 1041 (1060) 204 (104–428) 332 (352)
Total direct cost (adjusted) 465 (217–738) 698 (884) 175 (92–386) 314 (345)
Indirect cost
Total indirect cost 969 (227–1873) 1410 (1419) 60 (9–186) 162 (299)
Total household cost
Total household cost 1882 (681–3826) 2450 (2035) 258 (125–695) 495 (596)
Total household cost
(adjusted)
1543 (681–3175) 2107 (1743) 237 (124–656) 477 (585)
Costs are per month per patient (Rs)
doi:10.1371/journal.pntd.0003431.t003
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those with BL leprosy (47%) is unlikely to be representative of the target population. It is likely
that patients with severe ENL were overrepresented in this population and the estimates of the
economic burden presented in this study are also therefore not representative. However it is
possible that patients recruited from this hospital had a higher than average household income
(transport costs may prevent poorer patients from gaining access to the hospital) thus lessening
the perceived economic impact of ENL.
Recommendations for further work
Further work is needed to evaluate the economic consequences of leprosy and to validate these
findings on a larger scale. Future studies could eliminate selection bias by recruiting patients
from the community. Estimates of household costs could be improved if cost data were collect-
ed prospectively, although data collection would take a long time and the process may be less
efficient with more drop-outs and missing data. In future studies it would be useful to collect
data on other comorbidities and their associated costs and in particular to identify any health
conditions that might complicate the treatment of leprosy/ENL.
Concluding remarks
Catastrophic health expenditure is common in low- and middle-income countries, [17] and
the high rate of catastrophic spending observed in households affected by ENL in this setting
was not surprising. Leprosy is associated with a high level of poverty, and patients with ENL
face the double insult of high levels of (predominantly private sector) healthcare use and poor
access to financial risk protection (prepayment) mechanisms. Increasing the availability of pre-
payment mechanisms is needed to reduce the level of out-of-pocket expenditure and protect
households from catastrophic payments.[18,19]
Indirect costs account for the majority of total household costs for ENL. Many households
in rural India rely heavily on manual labour (agriculture) to provide cash income on a day to
day basis and these households are vulnerable to significant reductions in income resulting
from ill-health of household members. Thus strategies that aim to develop more robust and
sustainable sources of income and protect against income loss would be an important compo-
nent of reducing household costs.
These findings are relevant to many people. Doctors should advise patients to present early
to an established leprosy centre and avoid seeking costly treatments with other private provid-
ers. Local providers of alternative and complementary therapies should be engaged and encour-
aged to refer patients for specialist treatment promptly. Other healthcare professionals
including social workers should be aware of the economic burden of ENL so they can fully un-
derstand the problems faced by patients and provide appropriate support. These findings are
important to academics across a range of disciplines from health economics to clinical medi-
cine. This study paves the way for research to better understand how leprosy impacts on the
consumption choices made by families over time. Future cost-effectiveness analyses of interven-
tions for leprosy and ENL that make use of these data on household costs will usefully contrib-
ute to discussions on resource allocation. Funding bodies should be made aware of the burden
of ENL and the importance of conducting research to better understand this neglected compli-
cation of leprosy.[20] Charities and donors need to understand the magnitude of economic bur-
den so that leprosy programmes can be adequately funded. Specifically if control strategies and
interventions for leprosy are to be socially viable, it is essential that policy makers acknowledge
the significant contributions to household costs of private sector provision and lost productivi-
ty. Since household costs of ENL are very high, interventions to prevent or reduce the duration
of ENL could be very cost-effective.
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